Not finding it? Sign in to also search OpenAlex live.
-
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer2021 Nature Communications article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 12 patents
Maik Luu, Zeno Riester, Adrian Baldrich, Nicole Reichardt, Samantha Yuille, Alessandro Busetti, +20 more
768citations -
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors2023 Journal of Clinical Investigation article Medicine Viral-associated cancers and disorders Open access
Agnes Bonifacius, Britta Lamottke, Sabine Tischer‐Zimmermann, Rebecca Schultze-Florey, Lilia Goudeva, Hans‐Gert Heuft, +30 more
44citations -
Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study2020 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent
Els M.E. Verdegaal, Monique K. van der Kooij, Marten Visser, Caroline E. van der Minne, Linda de Bruin, Pauline Meij, +8 more
29citations -
Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future2022 Frontiers in Immunology article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 9 patents
José Saura‐Esteller, Milon de Jong, Lisa A. King, Erik Ensing, Benjamin Winograd, Tanja D. de Gruijl, +2 more
195citations -
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer2020 Oncotarget article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 17 patents
Anders Handrup Kverneland, Magnus Pedersen, Marie Christine Wulff Westergaard, Morten Nielsen, Troels Holz Borch, Lars Rønn Olsen, +8 more
101citations -
Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial
Monique K. van der Kooij, Els M.E. Verdegaal, Marten Visser, Linda de Bruin, Caroline E. van der Minne, Pauline Meij, +7 more
11citations -
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy2024 Nature article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 1 patent
Hussein Sultan, Yoshiko Takeuchi, Jeffrey P. Ward, Naveen Sharma, Tiantian Liu, Vladimir Sukhov, +21 more
103citations -
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer2023 Journal for ImmunoTherapy of Cancer article Medicine Ovarian cancer diagnosis and treatment Open access
Els M.E. Verdegaal, Saskia J A M Santegoets, Marij J.P. Welters, Linda de Bruin, Marten Visser, Caroline E. van der Minne, +8 more
30citations -
Facts and Hopes on the Use of Artificial Intelligence for Predictive Immunotherapy Biomarkers in Cancer2022 Clinical Cancer Research article Medicine Radiomics and Machine Learning in Medical Imaging Open access
Narmin Ghaffari Laleh, Marta Ligero, Raquel Pérez-López, Jakob Nikolas Kather
56citations -
Integrated noninvasive diagnostics for prediction of survival in immunotherapy2024 Immuno-Oncology Technology article Medicine Radiomics and Machine Learning in Medical Imaging Open access
Melda Yeghaian, Zuhir Bodalal, Teresa M. Tareco Bucho, Ieva Kurilova, Christian U. Blank, Egbert Frederik Smit, +5 more
3citations